seed
Stage
2022
Founded
3
Investors
About
ORFonyx develops gene expression enhancement therapies targeting RNA to address previously untreatable diseases by upregulating specific proteins.
Explore ORFonyx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.